These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9817840)

  • 1. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
    Ultsch M; Lokker NA; Godowski PJ; de Vos AM
    Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
    Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T
    J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for agonism and antagonism of hepatocyte growth factor.
    Tolbert WD; Daugherty-Holtrop J; Gherardi E; Vande Woude G; Xu HE
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13264-9. PubMed ID: 20624990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.
    Chirgadze DY; Hepple JP; Zhou H; Byrd RA; Blundell TL; Gherardi E
    Nat Struct Biol; 1999 Jan; 6(1):72-9. PubMed ID: 9886295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor.
    Lokker NA; Presta LG; Godowski PJ
    Protein Eng; 1994 Jul; 7(7):895-903. PubMed ID: 7971951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
    Lietha D; Chirgadze DY; Mulloy B; Blundell TL; Gherardi E
    EMBO J; 2001 Oct; 20(20):5543-55. PubMed ID: 11597998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
    Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
    Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation.
    Chirgadze DY; Hepple J; Byrd RA; Sowdhamini R; Blundell TL; Gherardi E
    FEBS Lett; 1998 Jun; 430(1-2):126-9. PubMed ID: 9678607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.
    Cao T; Pan J; Li X; He Y; Jiang Y; Chang Y; Zhang Q; Lan Y; Wang H; Jiao W; Tian Z; Zhang L
    Cell Physiol Biochem; 2018; 48(4):1480-1491. PubMed ID: 30107380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new crystal form of the NK1 splice variant of HGF/SF demonstrates extensive hinge movement and suggests that the NK1 dimer originates by domain swapping.
    Watanabe K; Chirgadze DY; Lietha D; de Jonge H; Blundell TL; Gherardi E
    J Mol Biol; 2002 May; 319(2):283-8. PubMed ID: 12051906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.
    Schwall RH; Chang LY; Godowski PJ; Kahn DW; Hillan KJ; Bauer KD; Zioncheck TF
    J Cell Biol; 1996 May; 133(3):709-18. PubMed ID: 8636243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
    Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF).
    Gherardi E; Hartmann G; Hepple J; Chirgadze D; Srinivasan N; Blundell T
    Ciba Found Symp; 1997; 212():84-93; discussion 93-104. PubMed ID: 9524765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.
    Niemann HH
    Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
    Sakata H; Stahl SJ; Taylor WG; Rosenberg JM; Sakaguchi K; Wingfield PT; Rubin JS
    J Biol Chem; 1997 Apr; 272(14):9457-63. PubMed ID: 9083085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity.
    Cioce V; Csaky KG; Chan AM; Bottaro DP; Taylor WG; Jensen R; Aaronson SA; Rubin JS
    J Biol Chem; 1996 May; 271(22):13110-5. PubMed ID: 8662798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.
    Tolbert WD; Daugherty J; Gao C; Xie Q; Miranti C; Gherardi E; Vande Woude G; Xu HE
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14592-7. PubMed ID: 17804794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
    Rubin JS; Day RM; Breckenridge D; Atabey N; Taylor WG; Stahl SJ; Wingfield PT; Kaufman JD; Schwall R; Bottaro DP
    J Biol Chem; 2001 Aug; 276(35):32977-83. PubMed ID: 11435444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
    Gherardi E; Sandin S; Petoukhov MV; Finch J; Youles ME; Ofverstedt LG; Miguel RN; Blundell TL; Vande Woude GF; Skoglund U; Svergun DI
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4046-51. PubMed ID: 16537482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.
    Kirchhofer D; Yao X; Peek M; Eigenbrot C; Lipari MT; Billeci KL; Maun HR; Moran P; Santell L; Wiesmann C; Lazarus RA
    J Biol Chem; 2004 Sep; 279(38):39915-24. PubMed ID: 15218027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.